Approximately 10–20% of MTCs are familial [56], developing in multiple endocrine neoplasia (MEN) 2A syndrome (Sipple’s syndrome), MEN 2B syndrome, and familial MTC, all having RET mutations as driver alteration [57]. Here, RET is linked to multiple endocrine neoplasia type 2A.